EnsoData releases AI-driven RPM 

MADISON, Wis. – EnsoData has added a new remote physiological monitoring (RPM) offering to the EnsoSleep PPG ecosystem of AI tools. The RPM solution allows clinicians to seamlessly monitor patients over time and proactively intervene when patients need support with their therapy the most. “The natural evolution for sleep care is in remote physiological monitoring from the home,” said Sam Rush, co-founder and chief AI officer for the company. “Until now, sleep medicine lacked an RPM solution that combined comfortable, wireless devices and an easily accessible physician web portal. Turning AHI into a daily vital sign empowers clinicians to manage therapy proactively to improve patient outcomes.” Patients using EnsoData’s RPM solution are monitored at home using comfortable ring, watch, or patch-based devices. Using only a PPG-based device, EnsoSleep PPG Study Management and the Celeste+ mobile application, the solution provides uniform AHI monitoring across all treatment modalities, including CPAP, implantable devices, oral appliances, and GLP-1s, the company says. "EnsoData’s RPM solution uses the same device for monitoring therapy as for testing, making it very user friendly for both patients and our team,” said Dr. Ernesto Eusebio, Sleep & Apnea Institute of Florida. “Our patients already understand the devices and the app from testing, so there’s no learning curve. Plus, our sleep staff can more easily track therapy progress, spot issues early, and provide timely support, all while accessing new billing codes to generate additional revenue beyond the testing phase.”